BAJAJ BROKING

Notification
No new Notification messages
Wagons Learning IPO is Open!
Apply for the Wagons Learning IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

16960

210435

VILINBIO

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

VILIN BIO MED LIMITED performance

Today’s low

Today’s high

₹ 28.00 ₹ 28.20
₹ 28.00

52 week low

52 week high

₹ 15.40 ₹ 32.50
₹ 28.00

Open Price

₹ 28.20

Prev. Close

₹ 28.00

Volume (Shares)

36000.00

Total traded value

₹ 10.08

Upper Circuit

₹ 29.40

Lower Circuit

₹ 26.60

info

VILIN BIO MED LIMITED Share Price Update

As of the latest trading session, VILIN BIO MED LIMITED share price is currently at ₹ 28, which is up by ₹ 0.00 from its previous closing. Today, the stock has fluctuated between ₹ 28.00 and ₹ 28.20. Over the past year, VILIN BIO MED LIMITED has achieved a return of 32.38 %. In the last month alone, the return has been 37.25 %. Read More...

VILIN BIO MED LIMITED fundamentals


  • Market cap (Cr)

    39.10

  • P/E Ratio (TTM)

    233.33

  • Beta

    -0.11

  • Book Value / share

    16.37

  • Return on equity

    0.95%

  • EPS (TTM)

    0.12

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    -0.04

info icon alternate text
  • Market cap (Cr)

    0.0

  • P/E Ratio (TTM)

    0.0

  • Beta

    0.0

  • Book Value / share

    0.0

  • Return on equity

    0.0%

  • EPS (TTM)

    0.0

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    0.0

info icon alternate text

VILIN BIO MED LIMITED Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars MAR 2023 (Values in Cr)
Revenue 3.30
Operating Expense 0.00
Net Profit -0.04
Net Profit Margin (%) -1.21
Earnings Per Share (EPS) 0.00
EBITDA 0.00
Effective Tax Rate (%) 0.00
Particulars DEC 2022 (Values in Cr)
Revenue 4.91
Operating Expense 0.00
Net Profit 0.73
Net Profit Margin (%) 14.86
Earnings Per Share (EPS) 2.21
EBITDA 0.00
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 15.80
Operating Expense 15.91
Net Profit 0.16
Net Profit Margin (%) 1.01
Earnings Per Share (EPS) 0.12
EBITDA 1.15
Effective Tax Rate (%) 26.08
Particulars MAR 2023 (Values in Cr)
Revenue 12.31
Operating Expense 10.56
Net Profit 1.25
Net Profit Margin (%) 10.15
Earnings Per Share (EPS) 1.25
EBITDA 2.60
Effective Tax Rate (%) 30.33
Particulars MAR 2022 (Values in Cr)
Revenue 11.21
Operating Expense 11.18
Net Profit 0.03
Net Profit Margin (%) 0.26
Earnings Per Share (EPS) 0.10
EBITDA 0.77
Effective Tax Rate (%) 25.00
Particulars MAR 2021 (Values in Cr)
Revenue 11.72
Operating Expense 11.55
Net Profit 0.12
Net Profit Margin (%) 1.02
Earnings Per Share (EPS) 0.37
EBITDA 0.86
Effective Tax Rate (%) 25.00
Particulars MAR 2020 (Values in Cr)
Revenue 16.81
Operating Expense 16.64
Net Profit 0.16
Net Profit Margin (%) 0.95
Earnings Per Share (EPS) 0.49
EBITDA 0.90
Effective Tax Rate (%) 15.78
Particulars MAR 2024 (Values in Cr)
Book Value / Share 16.37
ROE % 0.95
ROCE % 4.46
Total Debt to Total Equity 0.35
EBITDA Margin 7.28
Particulars MAR 2023 (Values in Cr)
Book Value / Share 10.73
ROE % 13.83
ROCE % 17.24
Total Debt to Total Equity 0.57
EBITDA Margin 21.12
Particulars MAR 2022 (Values in Cr)
Book Value / Share 22.41
ROE % 0.41
ROCE % 4.30
Total Debt to Total Equity 0.73
EBITDA Margin 6.87
Particulars MAR 2021 (Values in Cr)
Book Value / Share 22.31
ROE % 1.64
ROCE % 4.87
Total Debt to Total Equity 0.69
EBITDA Margin 7.34
Particulars MAR 2020 (Values in Cr)
Book Value / Share 21.94
ROE % 2.21
ROCE % 5.10
Total Debt to Total Equity 0.63
EBITDA Margin 5.47
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 6.04
Total Assets 32.40
Total Liabilities 32.40
Total Equity 22.84
Share Outstanding 13950000
Price to Book Ratio 1.16
Return on Assets (%) 0.50
Return on Capital (%) 0.55
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.03
Total Assets 17.67
Total Liabilities 17.67
Total Equity 10.67
Share Outstanding 9950000
Price to Book Ratio 0.00
Return on Assets (%) 7.04
Return on Capital (%) 7.98
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.03
Total Assets 13.55
Total Liabilities 13.55
Total Equity 7.39
Share Outstanding 3300000
Price to Book Ratio 0.00
Return on Assets (%) 0.24
Return on Capital (%) 0.26
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.04
Total Assets 13.89
Total Liabilities 13.89
Total Equity 7.36
Share Outstanding 3300000
Price to Book Ratio 0.00
Return on Assets (%) 0.87
Return on Capital (%) 0.94
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.06
Total Assets 14.00
Total Liabilities 14.00
Total Equity 7.24
Share Outstanding 3300000
Price to Book Ratio 0.00
Return on Assets (%) 1.15
Return on Capital (%) 1.38
Particulars MAR 2024 (Values in Cr)
Net Income 0.22
Cash from Operations -4.92
Cash from Investing 0.32
Cash from Financing 10.99
Net change in Cash 6.01
Free Cash Flow -4.92
Particulars MAR 2023 (Values in Cr)
Net Income 1.78
Cash from Operations -1.12
Cash from Investing -0.02
Cash from Financing 1.68
Net change in Cash 0.00
Free Cash Flow -1.09
Particulars MAR 2022 (Values in Cr)
Net Income 0.04
Cash from Operations 0.21
Cash from Investing 0.00
Cash from Financing -0.21
Net change in Cash 0.00
Free Cash Flow 0.21
Particulars MAR 2021 (Values in Cr)
Net Income 0.16
Cash from Operations -0.96
Cash from Investing 0.00
Cash from Financing 0.98
Net change in Cash -0.02
Free Cash Flow -0.96
Particulars MAR 2020 (Values in Cr)
Net Income 0.19
Cash from Operations -1.41
Cash from Investing -0.02
Cash from Financing 1.50
Net change in Cash 0.02
Free Cash Flow -1.39
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 36.46 19.60 1.99 279.41 34.11 / 77.70
BLISS GVS PHARMA LTD 119.00 15.60 1.24 1253.91 92.25 / 184.95
CIPLA LTD 1549.65 25.08 4.41 125155.99 1310.05 / 1702.00
FERMENTA BIOTECH LIMITED 260.70 21.60 2.64 767.27 145.00 / 449.00
GLAXOSMITHKLINE PHARMA LT 2959.45 58.70 29.97 50134.87 1924.30 / 3147.45
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 36.46 21.96 6.19 279.41 34.11 / 77.70
AMRUTAJAN HEALTH LTD 692.80 40.61 6.72 2002.93 548.05 / 861.40
ASTRAZENECA PHARMA IND LT 8665.50 129.24 31.88 21663.75 5000.00 / 9199.00
BLISS GVS PHARMA LTD 119.00 15.45 1.22 1253.91 92.25 / 184.95

VILIN BIO MED LIMITED Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
28.00 0.00 redarrow
red-green-graph indicator
16 Bearish
0 Bullish
  • 5 Days 29.00
  • 26 Days 25.70
  • 10 Days 28.40
  • 50 Days 23.80
  • 12 Days 28.00
  • 100 Days 22.30
  • 20 Days 26.50
  • 200 Days 21.80
28.07 PIVOT

First Support

27.98

First Resistance

28.23

Second Support

27.82

Second Resistance

28.32

Third Support

27.73

Third Resistance

28.48

RSI

63.72

ADX

29.33

MACD

2.04

Williams % R

-9.35

Commodity Channel Index (CCI)

76.84

Date

2025-04-28

Week

63200.00

Same Day

36000.00

Month

57647.00

1 Year

-0.11

3 Year

0.11

Over 1 Month

37.25%

down

Over 1 Year

32.38%

down

Over 3 Months

64.70%

down

Over 3 Years

0.00%

down

Over 6 Months

22.27%

down

Over 5 Years

0.00%

down

Invest with Confidence

Left Arrow
MTF boost
Buy Now. Pay Later

Boost your capital upto 5 X

img
IPO boost
Invest in IPOs
They give good returns
img
Right Arrow

VILIN BIO MED LIMITED shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
35.91%
Promoter Holdings
64.08%
FII
0.0%
DII
0.0%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Sadhanala Venkata Rao 4589705.0 (32.9%) Shareholding of Promoter and Promoter Group
Srinivasareddy Devireddy 1980795.0 (14.2%) Shareholding of Promoter and Promoter Group
Viswa Prasad Sadhanala 1848140.0 (13.25%) Shareholding of Promoter and Promoter Group
Resident Individuals Holding Nominal Share Capital In Excess Of Rs. 2 Lakhs 1196000.0 (8.57%) Public Shareholding
Percy Homi Italia 582000.0 (4.17%) Public Shareholding
Ramesh Reddy Sama 463234.0 (3.32%) Shareholding of Promoter and Promoter Group
Krishna 364000.0 (2.61%) Public Shareholding
Kashinath Sahu 250000.0 (1.79%) Public Shareholding
Chaitanya Kiran Vallapureddy 158665.0 (1.14%) Public Shareholding
Tanmayee Reddy Sama 21250.0 (0.15%) Shareholding of Promoter and Promoter Group
Anuj Bajpai 15000.0 (0.11%) Shareholding of Promoter and Promoter Group
Sama Ruchit Reddy 12500.0 (0.09%) Shareholding of Promoter and Promoter Group
Sneh Bajpai 9375.0 (0.07%) Shareholding of Promoter and Promoter Group

News

Left Arrow
Right Arrow

VILIN BIO MED LIMITED corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

VILIN BIO MED LIMITED Share Price

Vilin Bio Med Limited was originally incorporated on June 29, 2005, which commenced business on July 11, 2005 issued by Registrar of Companies, Andhra Pradesh, Hyderabad. The Company started its first commercial production in year 2006. In 2007, the Company expanded the Phase 2 for Beta Lactum facility with 16000 sft for Tablet, Capsule and Dry Syrup sections. In 2010, it acquired more than 1000 molecules Drug Approvals with different strengths in therapeutics of Diabetic, Neuro and Cardio.

The Company added the Sachet section in Non-Beta Lactum facility in 2014. The Company allotted a fresh issue of 40,00,000 Equity Shares of Rs 10/- each by its Initial Public Offering by raising funds aggregating to Rs 12 Crore on June 7, 2023 to the Public.

At present, Company is engaged in domestic business of manufacturing Pharmaceuticals products and the Manufacturing Unit is located in Roorkee, in the State of Uttarakhand. In order to maintain competitiveness and to further the cause of Healthcare, Company has laid a R&D Foundation and state of the art Manufacturing Facility in Roorkee. The major products for manufacturing dosage forms consist of Oral Liquid (Syrups/Suspensions/Dry Powders (ßeta & Non ßeta-Lactam), Tablets & Capsules (ßeta & Non ßeta-Lactam) and External Preparations.

Ointments along with similar products like Creams, Lotions, Gels or Pates are certain formulations primarily designed to be applied to the skin. Beta-Lactam are a group of medicines that are used to treat infections caused by some germs (bacteria and certain parasites). They do not work against infections that are caused by viruses - for example, the common cold or flu. There are various type of dosages in this group like Tablets, Capsules, Injection and Dry Syrups for Oral Solution. Non-Beta-Lactam Tablets & Capsule Products group medicines are generally used for general diseases like Cold, Flu, Fever, Anti-gastrological, Antimalaria,and several other viral diseases. Antibiotics are normally only prescribed for more serious bacterial infections, as many infections get better on their own.

Parent organization Indian Private
NSE symbol VILINBIO
Founded 2005
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Share Price of Vilin Bio Med Ltd?

Answer Field

The share price of Vilin Bio Med Ltd for NSE is ₹ 0 and for BSE is ₹ 0.00.

What is the Market Cap of Vilin Bio Med Ltd?

Answer Field

The market cap of Vilin Bio Med Ltd for NSE is ₹ 39.10 Cr. and for BSE is ₹ 0.0 Cr. as of now.

What is the 52 Week High and Low of Vilin Bio Med Ltd?

Answer Field

The 52 Week High and Low of Vilin Bio Med Ltd for NSE is ₹ 32.50 and ₹ 15.40 and for BSE is ₹ 0.00 and ₹ 0.00.

How to Buy Vilin Bio Med Ltd share?

Answer Field

You can trade in Vilin Bio Med Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Vilin Bio Med Ltd?

Answer Field

The 1 year returns on the stock has been 32.38%.

What is the Current Share Price of Vilin Bio Med Ltd?

Answer Field

Vilin Bio Med Ltd share price is for NSE ₹ 0 & for BSE ₹ 0.00 as on Apr 28 2025 12:00 AM.

What is the Market Cap of Vilin Bio Med Ltd Share?

Answer Field

The market cap of Vilin Bio Med Ltd for NSE ₹ 39.10 & for BSE ₹ 0.0 as on Apr 28 2025 12:00 AM.

What is the P/E Ratio of Vilin Bio Med Ltd Share?

Answer Field

As on Apr 28 2025 12:00 AM the price-to-earnings (PE) ratio for Vilin Bio Med Ltd share is 233.33.

What is the PB ratio of Vilin Bio Med Ltd Share?

Answer Field

As on Apr 28 2025 12:00 AM, the price-to-book (PB) ratio for Vilin Bio Med Ltd share is 16.37.

How to Buy Vilin Bio Med Ltd Share?

Answer Field

You can trade in Vilin Bio Med Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Vilin Bio Med Ltd Share on Bajaj Broking App?

Answer Field

To buy Vilin Bio Med Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Vilin Bio Med Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|